Soleno Therapeutics

Yahoo Finance • 12 hours ago

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Drug Risks: Levi & Korsinsky

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the period March 26, 2025 through November 4, 2025 may wish to evaluate lead plaintiff opportunitie... Full story

Yahoo Finance • 14 hours ago

Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or ot... Full story

Yahoo Finance • 3 days ago

SLNO ALERT: Hagens Berman Alerts Soleno (SLNO) Investors to Pending Securities Fraud Class Action and Upcoming May 5th Lead Plaintiff Deadline

SAN FRANCISCO, April 10, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action and the upcoming May 5, 2026 lead p... Full story

Yahoo Finance • 4 days ago

DEADLINE ALERT for EOSE, SLNO, NKTR, DRVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., April 10, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 5 days ago

INVESTOR ALERT: Soleno Therapeutics Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – RGRD Law

SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025, inclusive (the “Class Period”)... Full story

Yahoo Finance • 7 days ago

Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 7 days ago

Neurocrine to acquire Soleno in $2.9bn transaction

Neurocrine Biosciences has signed a definitive agreement to acquire Soleno Therapeutics for $53.00 per share in cash, which represents $2.9bn in total transaction equity value. The transaction will expand Neurocrine’s portfolio in endocri... Full story

Yahoo Finance • 7 days ago

Soleno Therapeutics (SLNO) Soars 32% on $2.9-Billion Merger

Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the 10 Stocks With Unexpected Gains. Soleno Therapeutics soared by 32.31 percent on Monday to close at $52.25 apiece, as investors gobbled up shares following news that it is set to be acqu... Full story

Yahoo Finance • 7 days ago

Stocks Finish Higher on Iran Ceasefire Hopes

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.44%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.36%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.61%.  June E-mini S&P futures (ESM26) rose +0.64%, and June E-m... Full story

Yahoo Finance • 7 days ago

Nasdaq, S&P 500 Notch 4th Consecutive Gain Amid Uncertainty Around Iran War Ceasefire

US benchmark equity indexes closed higher Monday, with the Nasdaq Composite and the S&P 500 seeing a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 7 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Soleno Therapeutics, Inc. (Nasdaq – SLNO), Affinity Bancshares, Forian, Inc. (Nasdaq – FORA), Janus Henderson Group plc (NYSE - JHG)

BALA CYNWYD, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ac... Full story

Yahoo Finance • 8 days ago

Equities Mostly Rise Intraday, Oil Advances as Markets Monitor Ceasefire Prospects

US benchmark equity indexes were mostly higher intraday and oil prices rose as investors evaluated t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

Stocks Rise Amid Iran Ceasefire Hopes

The S&P 500 Index ($SPX) (SPY) today is up +0.27%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.19%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.41%.  June E-mini S&P futures (ESM26) are up +0.37%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 8 days ago

Soleno Therapeutics Soars as Neurocrine Unveils $2.9B All-Cash Buyout at $53 a Share

Soleno Therapeutics logo Key Points Neurocrine will acquire Soleno in an all-cash tender offer at $53 per share, valuing the deal at about $2.9 billion, funded with cash on hand and not subject to a financing condition. VYKAT XR, approve... Full story

Yahoo Finance • 8 days ago

Neurocrine Biosciences Details $2.9B Soleno Buyout, Touts Vykat XR as Potential Blockbuster

Neurocrine Biosciences logo 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking Neurocrine Biosciences (NASDAQ:NBIX) detailed its planned acquisition of Soleno Therapeutics on a conference call Monday, outlining the deal terms, the s... Full story

Yahoo Finance • 8 days ago

Ceasefire Prospects in Focus as US Equity Futures Trade Mixed Pre-Bell

US equity futures were mixed ahead of Monday's opening bell as traders weighed prospects for a Middl PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

SLNO Jumps As Deal Buzz Lifts Stocks

This article first appeared on GuruFocus. Soleno Therapeutics (NASDAQ:SLNO) is stealing the spotlight early Monday, jumping 26% premarket as deal talks drive the biggest moves. The surge follows reports that Neurocrine Biosciences (NASDA... Full story

Yahoo Finance • 8 days ago

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday Amid Ongoing Iran Conflict

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively trad PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman

SAN FRANCISCO, April 06, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno common stock between March 26, 2025 a... Full story

Yahoo Finance • 8 days ago

This Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.

Soleno Therapeutics stock surged 40% in premarket trading Monday after Neurocrine Biosciences announced it had agreed to buy the company in a deal worth $2.9 billion. Neurocrine Biosciences said that it had agreed to buy Soleno—the maker o... Full story